Prolactinomas are the most prevalent functional pituitary adenomas and can result in a proliferative endocrine disorder that is typically highly responsive to medical therapy www.thelancet.com/journals/lan...
#prolactinomas
#hyperprolactinaemia
#pituitary #adenomas
#MedSky #EndoSky #OncSky
06.03.2026 17:13
👍 0
🔁 1
💬 0
📌 0
Despite oral corticosteroid replacement therapy, people with #Addison's disease have increased mortality in addition to reduced HRQoL and working ability thelancet.com/journals/lan...
#adrenal insufficiency
#adrenal crisis
25.01.2026 11:55
👍 3
🔁 1
💬 0
📌 1
08.10.2025 22:38
👍 0
🔁 0
💬 1
📌 0
Pituitary Advances in the Spotlight: 2025 Rapid-Fire Webinar
Free Webinar November 10th ! Register for a discussion of all new and ' cool' in the pituitary arena, clinical and research, new medications in development, new guidelines. Large multidisciplinary international panel led by @mariafleseriu.bsky.social &ShlomoMelmed
events.zoom.us/ev/AkPglLvFf...
08.10.2025 22:36
👍 0
🔁 0
💬 1
📌 0
Delighted to share Commentary from #Pituitary, the official journal of @pituitarysociety.bsky.social who endorse the newly Revised ESE Guideline👉 ow.ly/JUOc50WCJTJ
@geraldraverot.bsky.social
12.08.2025 12:18
👍 2
🔁 2
💬 0
📌 0
Happy to share our recent #consensus #guideline on how to multidisciplinary manage #pituitary #incidentalomas; good news on data to recommend less frequent #imaging for many microadenomas , but also smaller macroadenomas. @pituitarysociety.bsky.social @ohsubrain.bsky.social @ohsunews.bsky.social
24.06.2025 15:30
👍 11
🔁 3
💬 0
📌 0
Thromboprophylaxis in patients with endogenous Cushing's remains a hot topic. Our just released Position Statement is available at DOI: 10.1093/ejendo/lvaf017
03.03.2025 21:51
👍 1
🔁 1
💬 0
📌 0